The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

“CSL has an outstanding track record over the long term,” said David Grace of the Australian Foundation Investment Company, which owns about A$629 million of the company’s shares and has been invested ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

The new treatment is painful and expensive ... Last May, a 12-year-old with sickle cell anemia was the first person to receive a new gene therapy to treat the disease. The process is painful ...

Anemia is a growing illness, observed in women. Characterised by fatigue, skin pallor, shortness of breath, lightheadedness, ...

Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...

Now that the election is behind us, market watchers are digging into what Trump’s victory could mean for the economy in the coming months. As ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) - a rare, life-threatening disorder in which bone marrow ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.

HAIFA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company leveraging its proprietary platform for cell-based solutions to create ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...